- Home
- MIST vs ETON Comparison
MIST vs ETON Comparison
Compare MIST & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ETON
- Stock Information
- Founded
- MIST 2003
- ETON 2017
- Country
- MIST Canada
- ETON United States
- Employees
- MIST N/A
- ETON N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- MIST Health Care
- ETON Health Care
- Exchange
- MIST Nasdaq
- ETON Nasdaq
- Market Cap
- MIST 89.8M
- ETON 428.5M
- IPO Year
- MIST N/A
- ETON 2018
- Fundamental
- Price
- MIST $1.94
- ETON $14.99
- Analyst Decision
- MIST Strong Buy
- ETON Strong Buy
- Analyst Count
- MIST 2
- ETON 3
- Target Price
- MIST $7.50
- ETON $29.67
- AVG Volume (30 Days)
- MIST 566.3K
- ETON 605.6K
- Earning Date
- MIST 08-07-2025
- ETON 08-07-2025
- Dividend Yield
- MIST N/A
- ETON N/A
- EPS Growth
- MIST N/A
- ETON N/A
- EPS
- MIST N/A
- ETON N/A
- Revenue
- MIST N/A
- ETON $48,327,000.00
- Revenue This Year
- MIST N/A
- ETON $103.21
- Revenue Next Year
- MIST N/A
- ETON $51.34
- P/E Ratio
- MIST N/A
- ETON N/A
- Revenue Growth
- MIST N/A
- ETON 40.88
- 52 Week Low
- MIST $0.63
- ETON $3.22
- 52 Week High
- MIST $2.75
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- MIST 65.73
- ETON 43.76
- Support Level
- MIST $1.86
- ETON $13.51
- Resistance Level
- MIST $1.97
- ETON $14.70
- Average True Range (ATR)
- MIST 0.10
- ETON 0.74
- MACD
- MIST 0.00
- ETON 0.12
- Stochastic Oscillator
- MIST 80.00
- ETON 88.30
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.